In-vitro cytotoxicity and in-vivo antitumor activity of two platinum complexes with 1,3-dimethyl pentyl glycine ligand against breast cancer
暂无分享,去创建一个
[1] M. Mirzaei,et al. Property evaluation of two anticancer candidate platinum complexes with N-isobutyl glycine ligand against human colon cancer , 2022, BioMetals.
[2] B. Pereira,et al. The influence of acute kidney disease on the clinical outcomes of patients who received cisplatin, carboplatin, and oxaliplatin , 2022, Health science reports.
[3] Mahdie Rahban,et al. Anticancer activity of N-heteroaryl acetic acid salts against breast cancer; in silico and in vitro investigation , 2021, Molecular Biology Reports.
[4] Yao Sun,et al. Biomedical applications of Pt(II) metallacycle/metallacage-based agents: From mono-chemotherapy to versatile imaging contrasts and theranostic platforms , 2021 .
[5] S. Zolghadri,et al. The evaluation of the anti-Histone deacetylase, antibacterial, antioxidant and cytotoxic activities of synthetic N,N´-ethylenebis(α methylsalicylideneiminate) Schiff base derivatives , 2021 .
[6] R. Abdulah,et al. Antiproliferation Activity and Apoptotic Mechanism of Soursop (Annona muricata L.) Leaves Extract and Fractions on MCF7 Breast Cancer Cells , 2021, Breast cancer.
[7] H. Alkahtani,et al. New bis([1,2,4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation. , 2021, Bioorganic chemistry.
[8] Fereshteh Shiri,et al. Palladium and platinum complexes of folic acid as new drug delivery systems for treatment of breast cancer cells , 2021 .
[9] P. Pohl,et al. The Influence of Cold Atmospheric Pressure Plasma-Treated Media on the Cell Viability, Motility, and Induction of Apoptosis in Human Non-Metastatic (MCF7) and Metastatic (MDA-MB-231) Breast Cancer Cell Lines , 2021, International journal of molecular sciences.
[10] S. Zolghadri,et al. Two new oral candidates as anticancer platinum complexes of 1,3-dimethyl pentyl glycine ligand as doping agents against breast cancer. , 2021, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[11] T. Devasena,et al. Gold nanoparticles induced apoptosis via oxidative stress and mitochondrial dysfunctions in MCF‐7 breast cancer cells , 2020 .
[12] G. Zhu,et al. Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues. , 2020, Inorganic chemistry.
[13] R. Ahmad,et al. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway , 2020, BMC Cancer.
[14] S. Zolghadri,et al. Toxicity Effect of Bromoacetic Acid on MCF7 Breast Cancer Cell Line and Analysis of Expression of Apoptosis-Associated Genes , 2020 .
[15] W. El-Deiry,et al. Targeting apoptosis in cancer therapy , 2020, Nature Reviews Clinical Oncology.
[16] Zhifang Liu,et al. Synthesis and biological evaluation of new mono naphthalimide platinum(IV) derivatives as antitumor agents with dual DNA damage mechanism , 2020, Monatshefte für Chemie - Chemical Monthly.
[17] Burton B. Yang,et al. Ganoderma lucidum spore oil induces apoptosis of breast cancer cells in vitro and in vivo by activating caspase-3 and caspase-9. , 2020, Journal of ethnopharmacology.
[18] F. Ghiringhelli,et al. Platinum Derivatives Effects on Anticancer Immune Response , 2019, Biomolecules.
[19] A. Rapak,et al. In vitro effects of the activity of novel platinum (II) complex in canine and human cell lines. , 2019, Veterinary and comparative oncology.
[20] Muhammad Mohtasheemul Hasan,et al. Apoptosis induced by luteolin in breast cancer: Mechanistic and therapeutic perspectives. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[21] P. Alberti. Platinum-drugs induced peripheral neurotoxicity: clinical course and preclinical evidence , 2019, Expert opinion on drug metabolism & toxicology.
[22] Changwei Qiu,et al. Sodium selenite induces apoptosis via ROS‐mediated NF‐κB signaling and activation of the Bax–caspase‐9–caspase‐3 axis in 4T1 cells , 2018, Journal of cellular physiology.
[23] V. Gandin,et al. Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance , 2018, Chemical science.
[24] Shuqian Wang,et al. Bcl-2 promotes metastasis through the epithelial-to-mesenchymal transition in the BCap37 medullary breast cancer cell line , 2018, Oncology letters.
[25] Caixia Yang,et al. Current Status for Oral Platinum (IV) Anticancer Drug Development , 2018 .
[26] C. Vlad,et al. Platinum derivatives: a multidisciplinary approach. , 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[27] H. McCarthy,et al. Evaluation of the Impact of Nitric Oxide on Resistance to Platinum-Based Chemotherapeutics. , 2017 .
[28] J. Burda,et al. Reduction Process of Tetraplatin in the Presence of Deoxyguanosine Monophosphate (dGMP): A Computational DFT Study. , 2016, Chemistry.
[29] Sunhee Choi,et al. Oxidation of 5′-dGMP, 5′-dGDP, and 5′-dGTP by a platinum(IV) complex , 2015, JBIC Journal of Biological Inorganic Chemistry.
[30] C. Gourley,et al. Relevant Cancer Diagnoses, Commonly Used Chemotherapy Agents and Their Biochemical Mechanisms of Action , 2015 .
[31] S. Qin,et al. Overexpression of Smac promotes Cisplatin-induced apoptosis by activating caspase-3 and caspase-9 in lung cancer A549 cells. , 2013, Cancer biotherapy & radiopharmaceuticals.
[32] Shonagh Walker,et al. The status of platinum anticancer drugs in the clinic and in clinical trials. , 2010, Dalton transactions.